Anmeldung erfolgt in Kürze...
Details werden geladen...
HER2-Directed Antibodies: 14 Products Compared
Zanidatamab beat trastuzumab head-to-head in first-line HER2-positive gastroesophageal cancer. How to choose among 14 HER2-directed antibodies, with Yara Abdou, MD.
Ähnliche Seiten
HER2 ADCs: Choosing Between T-DXd and T-DM1
https://www.medscape.com/c99/p10/two-her2-antibody-drug-conjugates-two-toxicity-profiles-2026a10016qqFDA Okays Tucatinib for HER2+ Breast Cancer Maintenance
https://www.medscape.com/viewarticle/fda-okays-tucatinib-her2-positive-breast-cancer-maintenance-2026a10011ngHER2 Tyrosine Kinase Inhibitors: Class Deep Dive
https://www.medscape.com/c99/p10/oral-her2-kinase-inhibitors-reach-first-line-breast-and-lung-2026a10016qaHealthy Lifestyle Tied to Better Health After Breast Cancer
https://www.medscape.com/viewarticle/higher-alignment-lifestyle-guidelines-linked-better-physical-2026a10012qgSonesitatug Vedotin Improves OS in Gastroesophageal Cancer
https://www.medscape.com/viewarticle/sonesitatug-vedotin-improves-survival-gastroesophageal-2026a10015cu